Editorial ArticleDeveloping custom lentiviruses and enhancing transduction for more effective gene therapy
Editorial ArticleNext-Generation Immunotherapy: Combining Virus-Specific T Cells with Other Immuno-Oncology Technologies to Treat Solid Tumors
Industry NewsCBD, the latest wellness craze, won’t cause users to fail a drug test—but its lesser known cousin CBN will
Industry NewsEisai's Anticancer Agent Halaven Approved for Treatment of Locally Advanced or Metastatic Breast Cancer in China